← Eichor
Condition: Hiv Positive Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Hiv Positive

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin
Phase 1 · 1 location(s) · Brigham and Women's Hospital · NCT05069688Integrating HIV Prevention With TB Household Contact Evaluation in Uganda
NA · 1 location(s) · University of Washington · NCT07119359Pragmatic Use of Next-generation Sequencing for Management of Drug-resistant Tuberculosis
NA · 1 location(s) · University of California, San Francisco · NCT05553236Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda
NA · 1 location(s) · Yale University · NCT05917210Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment
Phase 3 · 6 location(s) · Johns Hopkins University · NCT06497465Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Versus Darunavir/Cobicistat Plus Tenofovir/Emtricitabin
Phase 4 · 1 location(s) · José Antonio Mata Marín · NCT06907056High vs. Standard Dose Rifampicin for Effusive Tuberculous Pericarditis
Phase 2 · 2 location(s) · University of Cape Town · NCT04521803Collection of Blood for Multiple Collaborative Studies
Phase N/A · 1 location(s) · University of California, San Francisco · NCT01336855Atorvastatin to Reduce Inflammation After Tuberculosis Treatment Completion
Phase 2/Phase 3 · 1 location(s) · University of Cape Town · NCT04147286Thinking and Memory Problems in People With HIV
Phase N/A · 1 location(s) · National Institute of Neurological Disorders and Stroke (NIN · NCT01875588Vicente Ferrer HIV Cohort Study
Phase N/A · 1 location(s) · Rural Development Trust Hospital · NCT02454569Bring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB Treatment
NA · 5 location(s) · Johns Hopkins University · NCT05671718Cohort Study of HIV-positive People, Treated With Long Acting Antiretroviral Therapy
Phase N/A · 1 location(s) · Castagna Antonella · NCT05663580Screening Study for Cervical Pre-cancer and Cancer Prevention in South African Women.
Phase N/A · 1 location(s) · University of Pretoria · NCT02956031Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis
Phase 3 · 13 location(s) · ANRS, Emerging Infectious Diseases · NCT04145258SURVEILLANCE, ASSESSMENT AND DETECTION OF INFLUENZA ASSOCIATED RESPIRATORY INFECTIONS IN HIV POSITIVE AND NEGATIVE INDIV
Phase N/A · 2 location(s) · Centre for Infectious Disease Research in Zambia · NCT07030075Tulane Abdominal Transplant Institute (TATI) of Solid Organ Transplantation of HIV-Positive Recipients From HIV-Positive
Phase N/A · 1 location(s) · Tulane University · NCT05159466Pre- and Post-treatment Lung Microbiota, Metabolome and Immune Signatures at the Site of Disease in Patients With Active
Phase N/A · 3 location(s) · University of Stellenbosch · NCT04700579REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE
Phase 4 · 10 location(s) · CAN Community Health · NCT07476339Bedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TB
Phase 2/Phase 3 · 6 location(s) · Johns Hopkins University · NCT06568484An Adaptive Randomized Controlled Trial
NA · 1 location(s) · Columbia University · NCT05633056Expanded Social Network Recruitment to HIV Testing (E-SNRHT) Intervention to Locate Undiagnosed Cases and Reduce HIV-rel
NA · 1 location(s) · University of Illinois at Chicago · NCT06857071Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa
Phase 3 · 1 location(s) · Biofabri, S.L · NCT04975178Positive Peers Intervention Clinical Trial
NA · 6 location(s) · MetroHealth Medical Center · NCT06388109This Study Evaluates the ALPCO Syphilis-T and Syphilis-NT CLIA Kits for Detecting Syphilis Antibodies in Serum and Plasm
Phase N/A · 6 location(s) · American Laboratory Products Company · NCT07089836Safety and Immunogenicity Following Meningococcal and Pneumococcal Immunization Among Adult People Living With HIV
Phase 4 · 1 location(s) · Thomas Benfield · NCT04875819Paradoxical Tuberculosis Reactions in Patients Without HIV Infection
Phase N/A · 2 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT04052022Community, Home-based Education, Screening Services Strategy to Increase Cervical Cancer Control Access for HIV-Positive
Phase N/A · 3 location(s) · Emory University · NCT06751030Assessing the Feasibility of Coach Mpilo for Men With TB and HIV
NA · 1 location(s) · Arizona State University · NCT071173702DR Versus 3DR in a Prospective Randomized Controlled Switch Trial
Phase 4 · 1 location(s) · University Hospital, Ghent · NCT04553081
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.